跳至主要内容
临床试验/NCT07312006
NCT07312006尚未招募不适用

Comparison of AirSeal to DV5 Insufflation in Gastric Sleeve Procedures - The "CAT5-GS" Study

SurgiQuest, Inc.2 个研究点 分布在 1 个国家目标入组 74 人开始时间: 2026年1月30日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
74
试验地点
2
主要终点
Pain Assessment on a 0 - 10 numerical rating scale (NRS)

研究概览

简要总结

A study to compare two different insufflation devices during robotic laparoscopic sleeve gastrectomy surgery, AirSeal to DV5 insufflation, in Gastric Sleeve Procedures. Shoulder, neck and chest pain will be assessed.

详细描述

A Single-Center, Prospective, Randomized, Controlled Study Comparing Intraoperative and Perioperative Outcomes using the CONMED AirSeal® and DV5 Insufflators during Robotic Laparoscopic Sleeve Gastrectomy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
22 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • - • Subject indicated for non-emergent sleeve gastrectomy surgery
  • Subjects (or appropriate legal representatives) able to provide written informed consent to participate in the study
  • Male or Female aged 22 years to 65 years
  • Have no significant psychopathology that could limit the subject's ability to understand the procedure, comply with medical, surgical, and/or behavioral recommendations and office visits
  • Agree to refrain from any type of elective procedures that would affect body weight such as abdominal lipoplasty or liposuction, mammoplasty, or removal of excess skin for the duration of the trial.
  • Are American Society of Anesthesiologists (ASA) Class I, II, or III);

排除标准

  • Subject participation in a different investigational clinical study within 90 days before screening and for the duration of this trial (unless previously approved by the investigator and Sponsor)
  • Subject requiring any surgical procedure in addition to Sleeve Gastrectomy
  • Previous malabsorptive or restrictive procedures performed for the treatment of obesity
  • Inability to provide informed consent
  • Unable or unwilling to attend follow-up visits and examinations
  • Uncontrolled hypertension (Systolic: ≥180 mmHg or Diastolic: ≥120 mmHg) and/or diabetes mellitus (Fasting blood sugar level: >200 mg/dL)
  • Subject who falls into American Society of Anesthesiologists (ASA) Class ≥ IV
  • History of chronic alcohol or drug abuse within 2 years of the screening visit
  • Chronic renal failure or on dialysis
  • Significant complicating medical history or immunocompromised
  • Subject is undergoing surgery for malignant disease
  • History or presence of pre-existing autoimmune connective tissue disease, e.g., systemic lupus erythematosus or scleroderma
  • Immunocompromised such as that resulting from chronic oral steroid use, chemotherapeutic agents, or immune deficiency disorders
  • Any medical condition which precludes compliance with the study
  • Subject with any other clinically significant unstable medical disorder, life threatening disease, or conditions that, in the opinion of the investigator, may jeopardize the subject's well-being and/or the soundness of this clinical study or which would contra-indicate a surgical procedure
  • Previous or current history of being on regular analgesia / pain killers
  • Advanced refusal of blood transfusion, (if necessary)
  • If female subject pregnant, planning to become pregnant within 3 months (up to 92 days of procedure), or lactating

结局指标

主要结局

Pain Assessment on a 0 - 10 numerical rating scale (NRS)

时间窗: 48 hours after surgery

Post-Operative shoulder, neck, chest pain, and abdominal pain

次要结局

  • Time(1) Evening Surgery Day- (at 8 PM) 2) Morning- (Day 1 at 8:00 AM) 3) Evening- (Day 1 at 8 PM) 4) Morning -(Day 2 at 8 AM.) 5) Evening- (Day 2 at 8 PM))

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验